Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

‘Innovation’ nation

China is finally embracing biopharmaceutical innovation, but it is innovation that looks different from that in the West.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Size of pool of Chinese students in the United States annually from 2000 to 2018.
Fig. 2: Private investment in Chinese and European biotech companies.
Fig. 3: Countries where key discoveries for new therapeutic modalities have been made since biotech’s inception.
Fig. 4: Granted Chinese invention biotech patents by country of first filing, 2009–2018.
Fig. 5: Lagging life sciences.

Author information

Authors and Affiliations


Corresponding author

Correspondence to Brady Huggett.

Supplementary material

Supplementary Table 1

Ties to the West

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huggett, B. ‘Innovation’ nation. Nat Biotechnol 37, 1264–1276 (2019).

Download citation

  • Published:

  • Issue Date:

  • DOI:


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing